imatinib
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of chronic myeloid leukemia (CML) in adults and children, acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01EA01
Manufacturer: Novartis Pharma Stein AG (full-cycle manufacturing)
-
The drug is prescribed for the treatment of chronic myeloid leukemia (CML) in adults and children, acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01EA01
Manufacturer: Novartis Pharma Stein AG (full-cycle manufacturing)
-
The drug is prescribed for the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01XE01
Manufacturer: Hetero Labs Limited
-
The drug is used to treat chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative neoplasms (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also indicated for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01XE01
Manufacturer: Hetero Labs Limited
-
The drug is prescribed for the treatment of adults and children with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ALL), myelodysplastic/myeloproliferative diseases, hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), as well as dermatofibrosarcoma protuberans (DFSP).
Form: capsules, hard
Active substance Dosage imatinib 100 mg ATC: L01EA01
Manufacturer: JSC "Grendix"
-
The drug is used to treat certain types of blood cancer (e.g., chronic myeloid leukemia and acute lymphoblastic leukemia), myelodysplastic diseases, hypereosinophilic syndrome, as well as for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma.
Form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01XE01
Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))
-
The drug is used to treat certain types of blood cancer (chronic myeloid leukemia and acute lymphoblastic leukemia), myelodysplastic diseases, hypereosinophilic syndrome, as well as gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma.
Form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01XE01
Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))
-
The drug is prescribed for the treatment of adults and children with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), or chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: capsules
Active substance Dosage imatinib 400 mg ATC: L01EA01
Manufacturer: Syndan Pharma S.R.L.
-
The drug is used to treat adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: capsules
Active substance Dosage imatinib 100 mg ATC: L01EA01
Manufacturer: Syndan Pharma S.R.L.
-
The drug is prescribed for the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01EA01
Manufacturer: Remedika LTD
-
The drug is used to treat various types of leukemia (chronic myeloid and acute lymphoblastic), myelodysplastic syndrome, hypereosinophilic syndrome, as well as gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma.
Form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01EA01
Manufacturer: Remedika LTD
-
The drug is indicated for the treatment of adults and children with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases, hypereosinophilic syndrome, and chronic eosinophilic leukemia. It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01EA01
-
The drug is used for the treatment of adults and children with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic syndromes, hypereosinophilic syndrome, as well as for the treatment of certain types of tumors (GIST and desmoid tumors).
Form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01EA01